Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nano.2021.102503 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "A dabigatran etexilate phospholipid complex nanoemulsion system for further oral bioavailability by reducing drug-leakage in the gastrointestinal tract" [Nanomedicine: Nanotechnology, Biology, and Medicine 14 (2018) 1455-1464/NANO 1647].
Nanomedicine
February 2022
Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China. Electronic address:
Corrigendum to "Effectiveness and Safety of Oral Anticoagulants in Adults with Non-valvular Atrial Fibrillation Patients and Concomitant Coronary/Peripheral Artery Disease" American Journal of Medicine 131:09 (2018): 1074-1085.e4.
Am J Med
October 2020
Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
There were 33,269 apixaban-warfarin, 9,345 dabigatran-warfarin, and 42,156 rivaroxaban-warfarin matched pairs, with a median follow-up of 4-5 months. Compared with warfarin, apixaban was associated with lower rates of stroke/systemic embolism (hazard ratio [HR] 0.52; 95% confidence interval [95% CI], 0.
View Article and Find Full Text PDFCorrigendum: Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs.
Front Neurol
January 2020
Department of Science of Health, University Magna Graecia of Catanzaro, Catanzaro, Italy.
[This corrects the article DOI: 10.3389/fneur.2018.
View Article and Find Full Text PDFCorrigendum to: Adherence to dabigatran etexilate in atrial fibrillation patients intended to undergo electrical cardioversion.
Eur Heart J Cardiovasc Pharmacother
April 2019
[This corrects the article on p. 127 in vol. 11, PMID: 30100750.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!